4 recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 4 |
Follow Panuveitis: new trials by email Literature Review of Panuveitis trials Research Report on Panuveitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases BCMA-CD19 CAR-T therapy - Systemic Lupus Erythematosus, Inflammatory Myopathy | Phase 2 | Recruiting | Peking University People's Hospital | 50 | 2024-12-26 | 2025-04-02 |
| Baricitinib in the Treatment of Intestinal Behçet's Syndrome Baricitinib, Adalimumab - Behcet Syndrome, Intestinal Type | Phase 2 | Recruiting | Peking Union Medical College Hospital | 56 | 2024-11-08 | 2026-09-21 |
| Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases Filgotinib - Behcet's Disease, Idiopathic Inflammatory Myopathies | Phase 2 | Recruiting | UMC Utrecht | 60 | 2024-03-12 | 2026-05-12 |
| Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome tocilizumab, tofacitinib, cyclophosphamide - Aneurysm, Behcet Syndrome, Vascular Type | Phase 2 | Recruiting | Peking Union Medical College Hospital | 81 | 2023-06-01 | 2024-08-19 |
Behcet Syndrome (4) · Immunoglobulin G4-Related Disease (2) · Myositis (2) · Aneurysm (1) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Antiphospholipid Syndrome (1) · Lupus Erythematosus, Systemic (1) · Purpura, Thrombotic Thrombocytopenic (1) · Scleroderma, Systemic (1) · Sjogren's Syndrome (1)
Cardiovascular Diseases (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Eye Diseases (4) · Genetic Diseases, Inborn (4) · Hereditary Autoinflammatory Diseases (4) · Mouth Diseases (4) · Skin Diseases (4) · Skin Diseases, Genetic (4) · Skin Diseases, Vascular (4) · Skin and Connective Tissue Diseases (4) · Stomatognathic Diseases (4) · Uveal Diseases (4) · Uveitis (4) · Uveitis, Anterior (4)
Adalimumab (1) · Cyclophosphamide (1) · GLPG0634 (1) · baricitinib (1) · tocilizumab (1) · tofacitinib (1)
Peking Union Medical College Hospital (2) · Peking University People's Hospital (1) · UMC Utrecht (1)
China (3) · Netherlands (1)
Jaap M van Laar, Prof. dr. (1) · Zhanguo Li (1)